PLUS1
1.78
-0.10 (-5.32%)
-0.10 (-5.32%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 155,806 |
|
|||||
| News | - | ||||||
| Day High | 1.85 | Low High |
|||||
| Day Low | 1.73 | ||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cardiol Therapeutics Inc | CRDL | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -0.10 | -5.32% | 1.78 | 20:00:01 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.85 | 1.73 | 1.85 | 1.78 | 1.88 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 786 | 155,806 | $ 1.78 | $ 277,365 | - | 1.55 - 4.96 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:00 | 875 | $ 1.78 | USD |
Period:
Draw Mode:
Cardiol Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 105.55M | 59.30M | 59.30M | $ - | $ - | - | -2.30 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | - |
Cardiol Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CRDL Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.94 | 1.95 | 1.63 | 1.79 | 364,291 | -0.16 | -8.25% |
| 1 Month | 1.86 | 2.36 | 1.55 | 1.98 | 558,644 | -0.08 | -4.3% |
| 3 Months | 2.61 | 2.63 | 1.55 | 2.11 | 578,131 | -0.83 | -31.8% |
| 6 Months | 2.63 | 4.96 | 1.55 | 3.15 | 750,968 | -0.85 | -32.32% |
| 1 Year | 2.63 | 4.96 | 1.55 | 3.15 | 750,968 | -0.85 | -32.32% |
| 3 Years | 2.63 | 4.96 | 1.55 | 3.15 | 750,968 | -0.85 | -32.32% |
| 5 Years | 2.63 | 4.96 | 1.55 | 3.15 | 750,968 | -0.85 | -32.32% |
Cardiol Therapeutics Description
| Cardiol Therapeutics Inc is a clinical-stage life sciences company developing therapies for cardiovascular disease (CVD). The lead product, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation being investigated in a Phase II/III study in hospitalized patients testing positive for COVID-19 with a prior history of, or risk factors for, CVD. The CardiolRx is also being investigated in patients with acute myocarditis, a leading cause of cardiac death in people less than 35 years old. |
